MVA85A-IMX313: Phase I started

Imaxio said researchers at the Jenner Institute at Oxford University began a single-blind, dose-escalation, U.K. Phase I trial to evaluate intradermal MVA85A-IMX313 vs. MVA85A alone in about 30 healt...